REMIT-iGlarLixi: Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches – results of a randomised controlled trial
Diabetes, Obesity and Metabolism
N McInnes, S Hall, HA Lochnan, SB Harris, Z Punthakee, RJ Sigal, I Hramiak, M Azharruddin, JF Liutkus, JF Yale, F Sultan, A Smith, RE Otto, D Sherifali, YY Liu, HC Gerstein
August 2023